Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin nebulization in inhalation burn injury
NCT01454869Phase 3Withdrawn
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2012
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in Inhalation injury, sponsored by Tehran University of Medical Sciences. Planned start Feb 2012; status: withdrawn.
02
Drugs
heparin
03
Conditions
Inhalation injury
Beyond the preview
Go deeper on NCT01454869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454869.